Genotyping of human papillomavirus and TP53 mutaions at exons 5 to 7 in lung cancer patients from Iran

BioImpacts

Volumn 3, Issue 3, 2013, Pages 135-140

  Jafari, Hossein ^a   Gharemohammadlou, Reza ^a   Fakhrjou, Ashraf ^a   Ebrahimi, Ayyub ^a   Nejati Koshki, Kazem ^a   Nadri, Mahsa ^a   Sakhinia, Ebrahim ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human Papillomaviruses; Squamous Cell Carcinoma; TP53 Mutations

Indexed keywords

VIRUS DNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EXON; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IRAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MUTATIONAL ANALYSIS; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WART VIRUS;

EID: 84887389659     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2013.018     Document Type: Article

References (27)

1. Prabhu PR, Jayalekshmi D, Pillai MR. Lung cancer and human papilloma viruses (HPVs): Examining the molecular evidence. J Oncol 2011;2012:750270.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2009;59:225-49.
3. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008;123:1-7.
4. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75:191-202.
5. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6:359-63.
6. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE. Prevalence of human papillomaviruses in lung carcinomas: A study of 218 cases. Mod Pathol 2005;18:1606-9.
7. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role of human papillomavirus in lung cancer: A review of the evidence. Am J Med Sci 2009;338:64-7.
8. Srinivasan M, Taioli E, Raqin CC. Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis 2009;30:1722-8.
9. Hausen HZ. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111:581-7.
10. Munoz N, Bosch FX, De sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
11. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol 2002;55:885-91.
12. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009;65:13-8.
13. Wang Y, Wang A, Jiang R, Pan H, Huang B, Lu Y, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep 2008;20:333-9.
14. Yu Y, Yang A, Hu S, Yan H. Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 2009;21:1627-32.
15. Guimaraes DP, Hainaut P. TP53: A key gene in human cancer. Biochimie 2002;84:83-93.
16. Campling BG, El-Deiry Ws. Clinical implication of p53 mutation in lung cancer. Mol Biotechnol 2003;24:141-56.
17. Mogi A, Kuwano H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011;2011:583929.
18. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003;21:229-39.
19. Soussi T, Beroud C. Assessing TP53 status in human tumors to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-9.
20. Mohammadi A, Vaziri Gohar A, Shakibaie MR. Mutations in tumor suppressor TP53 gene in formalin- fixed, paraffin embedded tissues of squamous cell carcinoma (SCC) of lung cancer. Am J Biochem&Biotech 2008;4:1-6.
21. Fan H, Gulley ML. DNA extraction from paraffin-embedded tissues. Methods Mol Med 2001;49:1-4.
22. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28: 622-9.
23. Shafaghi B, Sabeti S, Mohammadi F, Bakayev V, Sheikhol-Eslami FM, Mohammad Taheri Z, et al. Detection of Human Papillomavirus in Squamous Cell Carcinoma of the Lung by Semi-nested PCR. Tanaffos 2004;3:15-21.
24. Zafer E, Ergun MA, Alver G, Sahin FI, Yavuzer S, Ekmekci A. Detection and typing of human papillomavirus in non-small cell lung cancer. Respiration 2004;71:88-90.
25. Asvadi Kermani I, Seifi S, Dolatkhah R, Asvadi Kermani A, Sakhinia E, Dastgiri S, et al. Human papilloma virus in head and neck squamous cell cancer. Iran J Cancer Prev 2012;5:21-6.
26. Lee EB, Jin G, Lee SY, Park JY, Kim MJ, Choi JE, et al. TP53 mutations in Korean patients with non-small cell lung cancer. J Korean Med Sci 2010;25:698-705.
27. Yu Y, Yang A, Hu S, Zhang J, Yan H. Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas. Clin Respir J 2013;7:27-33.